Sangiovanni Timothy J. reported grant involving 40,000 derivative units of ZEVRA THERAPEUTICS, INC. at $0.00 for $0 on May 28, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
SVP, Finance & Corp Controller
SVP, Finance & Corp Controller
Filed May 29, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
40,000Stock Option (right to buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
40,000Direct
Trade date
May 28, 2026Grant
Filed
May 29, 2026, 4:16 PM ET1-day reporting delay
Accession
0001434647-26-000037Code A · Transaction 95722
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 28, 2026Grant20,000$0.00$0Trade 95723
2 transaction rows in this filing. Joint filers share the same rows.

ZVRA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ZVRA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −15%1w ago −9.5%1d ago −5.5%
Returns since7d −8.5%30d +17%90d180d1y

Footnotes in full

F1: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on March 1, 2027, subject to the Reporting Person's continued service on such vesting date. F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3: The restricted stock units will vest and settle as to one third of the restricted stock units on March 1, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.